Complementing current report no 15/2020 of 10 February 2020 – Summary of the costs of issuing G series ordinary bearer shares
Report No 29/2020
Data: 11.05.2020
In addition to the current report no. 15/2020 of 10 February 2020, in the scope of paragraphs 12 and 13, the Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company”, “The Issuer”) provides information on:
(1) the total issuance costs including:
a) preparation and carrying out of the offer: PLN 541 051.20,
b) the remuneration of the subissuers: not applicable,
c) promotion of the offer: not applicable,
d) drawing up a prospectus and a supplement taking into account the costs of advice: not applicable,
e) other: 30 000,00 PLN.
The total cost is PLN 571 051.20.
Methods for settlement of costs in the books and financial statements:
In accordance with MSR 1 and MSR 32, the costs of issuing series G shares were settled in the books by reducing the excess issue value of the issued shares over their nominal value. The company reduced the reserve capital from the excess issue price over the obtained sale price of series G shares by the total costs, i.e. by PLN 571 051.20.
2) the average cost of a subscription per share subscribed: 0,79 PLN.
Costs have been rounded to two decimal places.
Detailed legal basis: § 16.1 points 12 and 13 of the Regulation of the Minister of Finance of 29 March 2018 on current and periodic information provided by issuers of securities and the conditions for recognition as equivalent information required by the law of a non-Member State (current information).